Inactive Instrument

Analyst Reco. Celladon Corp Nasdaq

Equities

News Highlights : Top Company News of the Day - Monday at 11 PM ET	Apr. 01	DJ
News Highlights : Top Company News of the Day - Monday at 7 PM ET	Apr. 01	DJ
Citigroup Adjusts Eiger BioPharmaceuticals Price Target to $3 From $4, Maintains Buy Rating	23-08-29	MT
Baird Adjusts Price Target on Eiger BioPharmaceuticals to $5 From $3, Maintains Outperform Rating	23-06-30	MT
BTIG Adjusts Eiger BioPharmaceuticals' Price Target to $48 from $57, Maintains Buy Rating	22-09-07	MT
EIGER BIOPHARMACEUTICALS : Wedbush Suspended Coverage on Eiger BioPharmaceuticals	21-10-11	MT
EIGER BIOPHARMACEUTICALS : Citigroup Adjusts Price Target on Eiger BioPharmaceuticals to $26 From $23, Maintains Buy Rating	21-05-11	MT
EIGER BIOPHARMACEUTICALS : Wedbush Lifts Price Target for Eiger BioPharmaceuticals to $23 From $22, Maintains Outperform Rating	21-03-10	MT
EIGER BIOPHARMACEUTICALS : Wedbush Adjusts Price Target for Eiger BioPharmaceuticals to $22 From $31, Maintains Outperform Rating	20-11-25	MT
EIGER BIOPHARMACEUTICALS : Wedbush Adjusts Price Target on Eiger BioPharmaceuticals to $31 From $32, Keeps Outperform Rating	20-11-06	MT
Eiger BioPharmaceuticals, Inc. Announces Sub-Analysis of Phase 2 Results Demonstrating High Response Rates to 'All-Oral' Lonafarnib-Ritonavir Regimen in Low Viral Load Hdv-Infected Patients At the International Liver Congress 2018	18-04-17	CI

No results for this search